This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Institut Gustave Roussy, National Institute of Health and Medical Research. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:




Years Active: 2025
Title: Valérie Salgues: Innovator in Cancer Treatment
Introduction
Valérie Salgues is a notable inventor based in Nogent Sur Marne, France. He has made significant contributions to the field of medicine, particularly in cancer treatment. His innovative work focuses on developing new compounds that can enhance the immune response against cancer cells.
Latest Patents
Valérie Salgues holds a patent for "Madrasin-derivative compounds, composition and uses thereof for treating cancer." This invention relates to new compounds intended for use as medicaments. Specifically, it aims to increase the presentation of Pioneer Translation Products (PTPs)-derived antigens by cancer cells, thereby stimulating an immune response. The patent also outlines methods for treating cancer, preventing metastasis, and improving therapeutic efficiency.
Career Highlights
Throughout his career, Valérie Salgues has worked with prestigious institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His work has been instrumental in advancing cancer treatment methodologies.
Collaborations
Valérie has collaborated with notable colleagues, including Sébastien Apcher and Mouad Alami. Their combined expertise has contributed to the development of innovative solutions in cancer research.
Conclusion
Valérie Salgues is a pioneering inventor whose work in cancer treatment showcases the potential of new compounds in enhancing immune responses. His contributions are vital in the ongoing fight against cancer, and his patent reflects a significant advancement in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile